Global Mono Rapid Testing Market Growth (Status and Outlook) 2023-2029

Global Mono Rapid Testing Market Growth (Status and Outlook) 2023-2029

Mono rapid testing is a type of point of care testing for the qualitative detection of mononucleosis heterophile antibodies in the whole blood. This test is only done for the diagnosis of infectious mononucleosis in the blood sample.

LPI (LP Information)' newest research report, the “Mono Rapid Testing Industry Forecast” looks at past sales and reviews total world Mono Rapid Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Mono Rapid Testing sales for 2023 through 2029. With Mono Rapid Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Mono Rapid Testing industry.

This Insight Report provides a comprehensive analysis of the global Mono Rapid Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Mono Rapid Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Mono Rapid Testing market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Mono Rapid Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Mono Rapid Testing.

The global Mono Rapid Testing market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Mono Rapid Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Mono Rapid Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Mono Rapid Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Mono Rapid Testing players cover Cardinal Health, ELITech Group, Sekisui Diagnostics, Thermo Fisher Scientific, Cortez Diagnostic, Quidel, Jant Pharmacal, Abbott and Jant Pharmacal, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Mono Rapid Testing market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Infectious Diseases Testing
Substance Abuse Testing

Segmentation by application
Hospitals
Clinic
Homecare Setting

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Cardinal Health
ELITech Group
Sekisui Diagnostics
Thermo Fisher Scientific
Cortez Diagnostic
Quidel
Jant Pharmacal
Abbott
Jant Pharmacal
EKF Diagnostics
Verywell Health
Medline Industries
AccuBioTech
LabCorp

Please note: The report will take approximately 2 business days to prepare and deliver.